H. Pylori

Helicobacter pylori (H. pylori) is a type of bacteria.

Many researchers believe that H. pylori is responsible for the majority of peptic ulcers, chronic gastritis and increases the risk of developing gastric cancer.

Symptoms of H. pylori may include gnawing or burning pain, nausea, vomiting, or loss of appetite.
ClinicalTrials.gov Study Details
Helicobacter Pylori Infection
A Phase 3 Randomized Multicenter Study to Evaluate the Efficacy and Safety of Open-Label Dual Therapy with Oral Vonoprazan 20 mg or Double-Blind Triple Therapy with Oral Vonoprazan 20 mg Compared to Double-Blind Triple Therapy with Oral Lansoprazole 30 mg Daily in Patients with Helicobacter Pylori Infection

Photo of Bharat K Misra M.D.
Gastroenterologist and Research Director Encore Borland Groover Clinical Research (EBGCR)
Clinical Research Location 4800 Belfort Road Jacksonville FL 32256 Contact Research: 9046800871
Return to top.

Contact Research

Ulcerative Colitis

Ulcerative colitis

Ulcerative colitis (UC) is an autoimmune response that causes inflammation and ulcers (sores) in your digestive tract. UC usually affects the rectum and lower part of the colon.

Symptoms of ulcerative colitis can include: diarrhea, abdominal pain, weight loss, inflammation of the eyes and skin.


ClinicalTrials.gov Study Details
Ulcerative Colitis (U-Accomplish)
Clinical Study Protocol M14-533 A Phase 3 Multicenter, Long-Term Extension Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) in Subjects with Ulcerative Colitis
Ulcerative Colitis (ECO-RESET)
ECO-RESET: A Phase 2B, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Multicenter Study to Assess Efficacy and Safety of SER‑287 in Adults with Active Mild-to-Moderate Ulcerative Colitis

Clinical Study Protocol M14-234 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis

Clinical Study Protocol M14-675 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Ulcerative Colitis

A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of GS-4875 in Subjects with Moderately to Severely Active Ulcerative Colitis


Contact Research

Physician Investigator

Photo of Bharat K Misra M.D.
Gastroenterologist and Research Director Encore Borland Groover Clinical Research (EBGCR)
Clinical Research Location 4800 Belfort Road Jacksonville FL 32256 Contact Research: 9046800871
Return to top.
Photo of Mark Fleisher M.D.
Gastroenterologist Encore Borland Groover Clinical Research
Clinical Research Location 4800 Belfort Road Jacksonville FL 32256 Contact Research: 9046800871
Return to top.